Cargando…
Comment on: Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777323/ https://www.ncbi.nlm.nih.gov/pubmed/32703021 http://dx.doi.org/10.1177/1120672120945103 |
| _version_ | 1784637043762003968 |
|---|---|
| author | Elkazza, Sumeia A Hogg, HD Jeffry Di Simplicio, Sandro Dlay, Satnam S |
| author_facet | Elkazza, Sumeia A Hogg, HD Jeffry Di Simplicio, Sandro Dlay, Satnam S |
| author_sort | Elkazza, Sumeia A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8777323 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87773232022-01-22 Comment on: Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion Elkazza, Sumeia A Hogg, HD Jeffry Di Simplicio, Sandro Dlay, Satnam S Eur J Ophthalmol Letter to the Editors SAGE Publications 2020-07-24 2022-01 /pmc/articles/PMC8777323/ /pubmed/32703021 http://dx.doi.org/10.1177/1120672120945103 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editors Elkazza, Sumeia A Hogg, HD Jeffry Di Simplicio, Sandro Dlay, Satnam S Comment on: Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion |
| title | Comment on: Ranibizumab and aflibercept intravitreal injection for treatment
naïve and refractory macular oedema in branch retinal vein occlusion |
| title_full | Comment on: Ranibizumab and aflibercept intravitreal injection for treatment
naïve and refractory macular oedema in branch retinal vein occlusion |
| title_fullStr | Comment on: Ranibizumab and aflibercept intravitreal injection for treatment
naïve and refractory macular oedema in branch retinal vein occlusion |
| title_full_unstemmed | Comment on: Ranibizumab and aflibercept intravitreal injection for treatment
naïve and refractory macular oedema in branch retinal vein occlusion |
| title_short | Comment on: Ranibizumab and aflibercept intravitreal injection for treatment
naïve and refractory macular oedema in branch retinal vein occlusion |
| title_sort | comment on: ranibizumab and aflibercept intravitreal injection for treatment
naïve and refractory macular oedema in branch retinal vein occlusion |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777323/ https://www.ncbi.nlm.nih.gov/pubmed/32703021 http://dx.doi.org/10.1177/1120672120945103 |
| work_keys_str_mv | AT elkazzasumeiaa commentonranibizumabandafliberceptintravitrealinjectionfortreatmentnaiveandrefractorymacularoedemainbranchretinalveinocclusion AT hogghdjeffry commentonranibizumabandafliberceptintravitrealinjectionfortreatmentnaiveandrefractorymacularoedemainbranchretinalveinocclusion AT disimpliciosandro commentonranibizumabandafliberceptintravitrealinjectionfortreatmentnaiveandrefractorymacularoedemainbranchretinalveinocclusion AT dlaysatnams commentonranibizumabandafliberceptintravitrealinjectionfortreatmentnaiveandrefractorymacularoedemainbranchretinalveinocclusion |